A new model for gonorrhea control in Canada: Surveillance, new way of selecting best therapeutics and maybe a vaccine? Gonorrhea resistance surveillance is of utmost importance as it allows for rapid treatment guidelines adjustments. The advent of rapid testing tools can help best select antibiotic choice thus decreasing the selective pressure on a single antibiotic. Data emerging about vaccine giving protection against gonorrhea makes us think that we may have a new tool in a

Gonorrhea rates in Manitoba and Saskatchewan are consistently 2-3 fold higher than the Canadian average. In Manitoba, absolute case counts soared from 2015 to 2020 – which partially explains why we’re seeing more disseminated gonococcal infection (DGI). However, it’s not the whole story, there does seem to be something special about the strains associated with disseminated infections. Learning Objectives Discuss the changing epidemiology of Gonorrhea in Canada Review the clinical features of Disseminated Gonococcal Infection

The GetaKit Project: At-Home HIV Self-Testing & STI Expansion in Ontario Wednesday, April 27, 2022 12:00 PM Eastern Time (US and Canada) Register now The COVID-19 pandemic shuttered access to sexual health services in Canada. In response, we implemented on July 20, 2020 the GetaKit project in Ontario, which offers free at-home HIV self-testing. Since implementing GetaKit, we have distributed over 2000 kits, with a positivity rate of 0.4-0.8%. Based on these implementation outcomes